What is the official website of Merck Group ?

The official website of Merck Group is http://www.merckgroup.com.

What is Merck Group's cybersecurity risk score?

Merck Group has an AI-generated cybersecurity risk score of 674 out of 1000, indicating a Weak security posture according to Rankiteo's assessment.

How many security incidents has Merck Group experienced?

According to Rankiteo, Merck Group currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Merck Group been affected by any supply chain cyber incidents ?

According to Rankiteo, Merck Group has been affected by a supply chain cyber incident involving Snowflake, with the incident ID MEREQUUNIMAEMGMGOOTOYSNOALLORARIPTIC1775528897.

Does Merck Group have SOC 2 Type 1 certification ?

According to Rankiteo, Merck Group is not certified under SOC 2 Type 1.

Does Merck Group have SOC 2 Type 2 certification ?

According to Rankiteo, Merck Group does not hold a SOC 2 Type 2 certification.

Does Merck Group comply with GDPR ?

According to Rankiteo, Merck Group is not listed as GDPR compliant.

Does Merck Group have PCI DSS certification ?

According to Rankiteo, Merck Group does not currently maintain PCI DSS compliance.

Does Merck Group comply with HIPAA ?

According to Rankiteo, Merck Group is not compliant with HIPAA regulations.

Does Merck Group have ISO 27001 certification ?

According to Rankiteo,Merck Group is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Merck Group operate in ?

Merck Group operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Merck Group have ?

Merck Group employs approximately 32,268 people worldwide.

Does Merck Group own any subsidiaries ?

Merck Group presently has no subsidiaries across any sectors.

How many LinkedIn followers does Merck Group have ?

Merck Group's official LinkedIn profile has approximately 1,643,572 followers.

What is the NAICS classification code for Merck Group ?

Merck Group is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Merck Group have a Crunchbase profile ?

No, Merck Group does not have a profile on Crunchbase.

Does Merck Group have a LinkedIn profile ?

Yes, Merck Group maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/merck-group.

How many cybersecurity incidents has Merck Group experienced ?

As of August 20, 2026, Rankiteo reports that Merck Group has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Merck Group have ?

Merck Group has an estimated 5,728 peer or competitor companies worldwide.

What types of cybersecurity incidents has Merck Group faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Merck Group

Boost Score +25 with badge (5 left)

674

/1000

Weak

699

/1000

Weak

Merck Group Vendor Cyber Rating & Cyber Score

merckgroup.com

Add Your Compliance Badge

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about

Merck Group A.I CyberSecurity Scoring

Scoring History

Merck Group

Merck Group CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Merck Group

Ransomware

100

12/2025

Snowflake

MEREQUUNIMAEMGM...

Loading…

A.I.

Merck Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Merck Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck Group in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Merck Group in 2026.

Incident Types Merck Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck Group in 2026.

Incident History - Merck Group (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Merck Group Subsidiaries

Merck Group

Pharmaceutical Manufacturing

Website: http://www.merckgroup.com

Company Size: 10,000+ employees

Merck Life ScienceBiotechnology Research

Merck HealthcarePharmaceutical Manufacturing

Merck ElectronicsChemical Manufacturing

Loading…

Merck Group Similar Companies

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Loading…

NEWS

Merck Group CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 19, 2026 07:00 AM

How The Investment Story For Merck KGaA (XTRA:MRK) Is Quietly Shifting On Cautious Targets

A small reset in fair value to €143.20, together with individual analyst targets moving to €135 from €150 and to €130 from €125,...

Read Article

March 06, 2026 08:00 AM

Germany’s Merck KGaA Expects Currency Headwinds to Weigh on Earnings

It projected lower adjusted earnings and flat sales at best for 2026.

Read Article

March 05, 2026 08:00 AM

Merck KGaA Q4 Earnings Call Highlights

Merck KGaA (ETR:MRK) executives told investors the company delivered “solid” organic growth in 2025 despite a challenging macroeconomic and...

Read Article

March 05, 2026 08:00 AM

Merck KGaA sees earnings drop on currency effects, MS drug

Germany's Merck KGaA projected 2026 adjusted operating profit to slip by as much as 9.8%, hurt by negative currency effects and the loss of...

Read Article

March 03, 2026 08:00 AM

List of Fortune 500 Chief Information Security Officers

Every one of our nation's biggest businesses has a cybersecurity leader. Scroll down the list to see who's who.

Read Article

January 14, 2026 08:00 AM

Is Merck KGaA (XTRA:MRK) Share Price Misaligned With Cash Flow And Earnings Valuation Estimates

If you are wondering whether Merck KGaA is offering fair value at its current share price, this article will walk you through what the...

Read Article

November 20, 2025 08:00 AM

Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's...

Read Article

November 13, 2025 08:00 AM

Germany’s Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results

The company's life-science segment—its largest by sales—benefited from strong demand from the pharma industry, continuing a recovery...

Read Article

November 12, 2025 08:00 AM

Merck KGaA's Q3 profit rises, beats market view

Merck KGaA on Thursday reported a slight gain in third-quarter operating earnings that beat market expectations, benefiting from legislative...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-76929

SUMMARY

Pcapng file parser crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service

Published

Date2026-08-19

Updated

Date2026-08-19

RISK INFORMATION (Score: 4.7)

cvss3

Base Score: 4.7

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

REFERENCES

CVE-2026-76928

SUMMARY

X.509IF protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service

Published

Date2026-08-19

Updated

Date2026-08-19

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-76927

SUMMARY

H.245 protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service

Published

Date2026-08-19

Updated

Date2026-08-19

RISK INFORMATION (Score: 4.7)

cvss3

Base Score: 4.7

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

REFERENCES

CVE-2026-76926

SUMMARY

BUSMASTER file parser abnormal exit in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service

Published

Date2026-08-19

Updated

Date2026-08-19

RISK INFORMATION (Score: 3.1)

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

1.6

REFERENCES

CVE-2026-76924

SUMMARY

Kerberos protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service

Published

Date2026-08-19

Updated

Date2026-08-19

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…